Novo Nordisk remains the GLP-1 leader with over 65% market share. Read an in-depth BVO stock analysis and why we rate it as a ...

Lundin Gold Inc. was the biggest leader among large stocks during the session, surging 10.8%, and Tomra Systems ASA increased 8.5%. Novo Nordisk A/S rounded out the top three leaders on Friday, with ...

Novo Nordisk has been losing big in the past year and is down over 66% from its peak in 2024. On the other hand, Eli Lilly ...

Q2 2025 Earnings Call Transcript August 6, 2025 Operator: Good day, and thank you for standing by. Welcome to the Q2 2025 ...

Novo Nordisk continues to deliver double-digit revenue and profit growth, driven by both its diabetes and obesity drug ...

AP Moller-Maersk shares rose in Copenhagen after the company reported strong earnings for the second quarter.

Orion Oyj Series A posted the largest decline among large stocks during the session, declining 7.8%, followed by Embla Medical hf. shares, which declined 7.7%. Shares of Orion Oyj Series B declined ...

Maziar Mike Doustdar, who was named as Novo Nordisk’s new CEO last week, spoke on a second quarter earnings call of ...

Novo Nordisk A/S (NYSE:NVO) on Wednesday reported second-quarter 2025 sales of roughly $11.68 billion (76.86 billion Danish ...

Novo Nordisk reported 18% sales growth in the first half of 2025, despite a profit warning that triggered a record share drop ...

Amidst challenging market environment DSV’s Q2 performance was bolstered by early gains from its acquisition of Schenker.